×óÑõ·úɳÐǶÔCOPD»¼ÕßÌåÄÚ¶àË÷²è¼îÒ©¶¯Ñ§µÄÓ°Ïì
Ä¿µÄ̽ÌÖÔÚÂýÐÔ×èÈûÐԷμ²²¡£¨chronic obstructive pulmonary disease£¬COPD£©»¼ÕßÌåÄÚÁªÓÃ×óÑõ·úɳÐÇ£¨1evofloxacin£¬LVFX£©ºÍ¶àË÷²è¼î£¨doxofylline£¬DFL£©Ê±£¬LVFX¶ÔDFLÒ©¶¯Ñ§µÄÓ°Ïì¡£·½·¨²ÉÓÃRP-HPLC²â¶¨COPD»¼Õßµ¥ÓÃDFL¼°ÓëLVFXÁªÓúóDFLµÄѪҩŨ¶È¡£ÓÃ3P97Èí¼þ½øÐÐÒ©¶¯Ñ§·ÖÎö£¬±È½ÏÁ½×éDFLÒ©¶¯Ñ§²ÎÊýµÄ±ä»¯¡£½á¹ûDFLµ¥ÓÃ×é¼°ÓëINFXºÏÓÃ×éÖ÷ÒªÒ©¶¯Ñ§²ÎÊý£¥·Ö±ðΪ£¨26£®53¡À11£®77£©ºÍ£¨19£®20¡À8£®28£©h£»t1/2¦Á·Ö±ðΪ£¨0£®05¡À0£®01£©ºÍ£¨0£®04¡À0£®01£©h£»t1/x¦Â·Ö±ðΪ£¨1£®72¡À0£®44£©ºÍ£¨1£®80¡À0£®41£©h£»AUC·Ö±ðΪ£¨31£®06¡À6£®29£©ºÍ£¨35£®28¡À7£®02£©mg¡¤h¡¤L^-1£»CLs·Ö±ðΪ£¨23£®64¡À5£®02£©ºÍ£¨20£®78¡À4£®77£©L¡¤h^-1¡£Á½×é¸÷Ò©¶¯Ñ§²ÎÊý²îÒì¾ùÎÞÏÔÖøÐÔ¡£½áÂÛLVFX¶ÔCOPD»¼ÕßDFLµÄÒ©¶¯Ñ§¹ý³ÌÎÞÓ°Ï죬ÌáʾÁ½ÕßÁªºÏÓ¦ÓÃÏà¶Ô°²È«¡£Íê³É»ú¹¹£º[1]Ö£ÖÝ´óѧµÚÒ»¸½ÊôÒ½Ôº,Ö£ÖÝ450052 [2]ºÓÄÏÊ¡Ö°¹¤Ò½Ñ§Ôº,Ö£ÖÝ451191